ストックスクリーナーアプリを入手
10.31
0.59%
0.06
アフターアワーズ：
10.56
0.25
+2.42%
前日終値:
$10.25
開ける：
$10.12
24時間の取引高:
1.01M
Relative Volume:
0.81
時価総額：
$1.67B
収益：
$360.69M
当期純損益:
$-61.40M
株価収益率:
85.92
EPS:
0.12
ネットキャッシュフロー:
$60.93M
1週間 パフォーマンス:
-0.39%
1か月 パフォーマンス:
-7.03%
6か月 パフォーマンス:
-41.42%
1年 パフォーマンス:
-19.52%
1日の値動き範囲:
$10.07
$10.39
1週間の範囲:
$10.05
$10.60
52週間の値動き範囲:
$9.99
$19.87
Certara Inc Stock (CERT) Company Profile
名前
Certara Inc
セクター
電話
(415) 237-8272
住所
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Certara Inc Stock (CERT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-10 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | 開始されました | JMP Securities | Mkt Perform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | UBS | Neutral |
| 2023-12-05 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | ダウングレード | Jefferies | Buy → Hold |
| 2023-08-10 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | 開始されました | Stephens | Overweight |
| 2023-04-03 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-12-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | 開始されました | Berenberg | Buy |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-01 | 開始されました | Piper Sandler | Overweight |
| 2022-01-11 | アップグレード | Jefferies | Hold → Buy |
| 2021-08-05 | 再開されました | Credit Suisse | Neutral |
| 2021-07-23 | 開始されました | Robert W. Baird | Outperform |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-06 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-01-05 | 開始されました | BofA Securities | Buy |
| 2021-01-05 | 開始されました | Credit Suisse | Neutral |
| 2021-01-05 | 開始されました | Jefferies | Hold |
| 2021-01-05 | 開始されました | William Blair | Outperform |
すべてを表示
Certara Inc (CERT) 最新ニュース
Robert W. Baird Issues Pessimistic Forecast for Certara (NASDAQ:CERT) Stock Price - MarketBeat
Certara stock target cut, maintains neutral rating amid spending concerns - Investing.com India
Certara price target lowered to $13 from $18 at Baird - TipRanks
Drug Discovery Informatics Market Size Set to Surpass USD - GlobeNewswire
Biosimulation Market Segments, Drivers, Restraints, And Trends For 2024-2033 - EIN News
Biosimulation Market is expected to Double Its Size by Upcoming - openPR
Certara (CERT) to Release Quarterly Earnings on Wednesday - MarketBeat
Certara to Participate in the Stephens Annual Investment Conference - ForexTV.com
Certara, Inc. (NASDAQ:CERT) Shares Could Be 23% Above Their Intrinsic Value Estimate - Yahoo Finance
How To Trade (CERT) - Stock Traders Daily
Certara (NASDAQ:CERT) Hits New 12-Month LowHere's Why - MarketBeat
Certara stock hits 52-week low at $10.35 amid market challenges - Investing.com
Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued? - Simply Wall St
Certara (NASDAQ:CERT) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Certara adds pharmaceutical veteran to board - Investing.com India
Analysts Set Certara, Inc. (NASDAQ:CERT) Target Price at $17.08 - MarketBeat
Globe Life Inc. (NYSE:GL) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Certara appoints new director to its board By Investing.com - Investing.com Australia
Certara Appoints John Reynders as Board Member - citybiz
Certara appoints new director to its board - Investing.com India
Certara Appoints John Reynders as New Independent Board Member - The Manila Times
Certara adds pharmaceutical veteran to board By Investing.com - Investing.com UK
380,638 Shares in Certara, Inc. (NASDAQ:CERT) Bought by Kopion Asset Management LLC - MarketBeat
Barclays Lowers Certara (NASDAQ:CERT) Price Target to $14.00 - MarketBeat
Beyond The Numbers: 4 Analysts Discuss Certara Stock - Benzinga
Trading Day Review: Certara Inc (CERT) Loses Momentum, Closing at 11.24 - The Dwinnex
Certara price target lowered to $14 from $16 at Barclays - TipRanks
Certara Inc (CERT) is looking forward to a strong quarter - SETE News
In Silico Clinical Trials Market 2024-2031- Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes - IndiaPolitics.com
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024 - ForexTV.com
Taking a Closer Look At Certara Inc (CERT) Following Its Recent Trade - Knox Daily
A stock that deserves closer examination: Certara Inc (CERT) - US Post News
Certara executive sells $59,661 in company stock By Investing.com - Investing.com Canada
Insider Sale at Certara Inc (CERT): President of Drug Developmen - GuruFocus.com
Certara executive sells $59,661 in company stock - Investing.com India
Patrick F. Smith Sells 5,409 Shares of Certara, Inc. (NASDAQ:CERT) Stock - MarketBeat
Financial Health Report: Certara Inc (CERT)’s Ratios Tell a Tale - The Dwinnex
This trade activity should not be overlooked: Certara Inc (CERT) - SETE News
Thrivent Financial for Lutherans Reduces Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Market Watch: Certara Inc (CERT)’s Noteworthy Gain, Closing at 11.37 - The Dwinnex
Clearbridge Investments LLC Has $56.61 Million Holdings in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara Completes Chemaxon Acquisition - citybiz
Certara acquires Chemaxon to enhance drug development - Investing.com India
Certara Completes Acquisition of Chemaxon - ForexTV.com
Certara acquires Chemaxon to enhance drug development By Investing.com - Investing.com UK
Monitoring Certara Inc (CERT) after recent insider movements - Knox Daily
Certara Inc (CERT) is a good investment, but the stock may be undervalued - US Post News
A new trading data show Certara Inc (CERT) is showing positive returns. - SETE News
Dimensional Fund Advisors LP Purchases 273,095 Shares of Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara Inc (CERT) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
High Growth Tech Stocks To Watch In September 2024 - Simply Wall St
Certara Inc (CERT) 財務データ
収益
当期純利益
現金流量
EPS
2.66%
0.07%
大文字化:
|
ボリューム (24 時間):